Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide

J Neurooncol. 2007 Oct;85(1):105-7. doi: 10.1007/s11060-007-9398-z. Epub 2007 May 16.

Abstract

We report the case of a 30-year-old woman with glioblastoma multiforme (GBM) treated with surgery followed by concomitant Temozolomide (TMZ) and external beam radiation, which she tolerated well without any interruptions. However, when she was being evaluated for adjuvant Temozolomide, she developed progressive decline in leukocyte counts and platelet counts and subsequently, febrile neutropenia with bleeding manifestations. A bone marrow aspiration and biopsy done showed a gross hypocellular bone marrow with very few erythriod and myeloid cells and no suggestion of progenitor cells, consistent with aplastic anemia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Aplastic / chemically induced*
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Blood Cell Count
  • Bone Marrow / pathology
  • Brain Neoplasms / complications*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / radiotherapy
  • Combined Modality Therapy
  • Dacarbazine / adverse effects
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / therapeutic use
  • Fatal Outcome
  • Female
  • Glioblastoma / complications*
  • Glioblastoma / drug therapy*
  • Glioblastoma / radiotherapy
  • Humans
  • Magnetic Resonance Imaging
  • Pancytopenia / blood
  • Pancytopenia / chemically induced
  • Sepsis / complications
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide